(15Z,18Z,21Z,24Z,27Z)-N-[(4E,8E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxytetratriaconta-4,8-dien-2-yl]triaconta-15,18,21,24,27-pentaenamide

C82H145NO18 — CID 165207437

IUPAC(15Z,18Z,21Z,24Z,27Z)-N-[(4E,8E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxytetratriaconta-4,8-dien-2-yl]triaconta-15,18,21,24,27-pentaenamide
SMILESCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCCCCCCCCCC(=O)NC(COC1OC(CO)C(OC2OC(CO)C(OC3OC(CO)C(O)C(O)C3O)C(O)C2O)C(O)C1O)C(O)/C=C/CC/C=C/CCCCCCCCCCCCCCCCCCCCCCCCC
InChIInChI=1S/C82H145NO18/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-32-34-35-37-39-41-43-45-47-49-51-53-55-57-59-66(87)65(83-70(88)60-58-56-54-52-50-48-46-44-42-40-38-36-33-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2)64-96-80-76(94)73(91)78(68(62-85)98-80)101-82-77(95)74(92)79(69(63-86)99-82)100-81-75(93)72(90)71(89)67(61-84)97-81/h6,8,12,14,18,20,24,26,30,33,49,51,57,59,65-69,71-82,84-87,89-95H,3-5,7,9-11,13,15-17,19,21-23,25,27-29,31-32,34-48,50,52-56,58,60-64H2,1-2H3,(H,83,88)/b8-6-,14-12-,20-18-,26-24-,33-30-,51-49+,59-57+
InChIKeyFCSMEKQLGBQKSX-ZGZGWSBGSA-N
MW1433.05 g/mol
LogP13.39
Rot. Bonds63

About (15Z,18Z,21Z,24Z,27Z)-N-[(4E,8E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxytetratriaconta-4,8-dien-2-yl]triaconta-15,18,21,24,27-pentaenamide

(15Z,18Z,21Z,24Z,27Z)-N-[(4E,8E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxytetratriaconta-4,8-dien-2-yl]triaconta-15,18,21,24,27-pentaenamide (PubChem CID 165207437) has the molecular formula C82H145NO18 and a molecular weight of 1433.05 g/mol. Its IUPAC name is (15Z,18Z,21Z,24Z,27Z)-N-[(4E,8E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxytetratriaconta-4,8-dien-2-yl]triaconta-15,18,21,24,27-pentaenamide.

Molecular Properties

Compound Name(15Z,18Z,21Z,24Z,27Z)-N-[(4E,8E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxytetratriaconta-4,8-dien-2-yl]triaconta-15,18,21,24,27-pentaenamide
PubChem CID165207437
Molecular FormulaC82H145NO18
Molecular Weight1433.05 g/mol
Exact Mass1432.05
IUPAC Name(15Z,18Z,21Z,24Z,27Z)-N-[(4E,8E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxytetratriaconta-4,8-dien-2-yl]triaconta-15,18,21,24,27-pentaenamide
SMILESCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCCCCCCCCCC(=O)NC(COC1OC(CO)C(OC2OC(CO)C(OC3OC(CO)C(O)C(O)C3O)C(O)C2O)C(O)C1O)C(O)/C=C/CC/C=C/CCCCCCCCCCCCCCCCCCCCCCCCC
InChIInChI=1S/C82H145NO18/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-32-34-35-37-39-41-43-45-47-49-51-53-55-57-59-66(87)65(83-70(88)60-58-56-54-52-50-48-46-44-42-40-38-36-33-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2)64-96-80-76(94)73(91)78(68(62-85)98-80)101-82-77(95)74(92)79(69(63-86)99-82)100-81-75(93)72(90)71(89)67(61-84)97-81/h6,8,12,14,18,20,24,26,30,33,49,51,57,59,65-69,71-82,84-87,89-95H,3-5,7,9-11,13,15-17,19,21-23,25,27-29,31-32,34-48,50,52-56,58,60-64H2,1-2H3,(H,83,88)/b8-6-,14-12-,20-18-,26-24-,33-30-,51-49+,59-57+
InChIKeyFCSMEKQLGBQKSX-ZGZGWSBGSA-N
XLogP13.39
TPSA307.01 Ų
H-Bond Donors12
H-Bond Acceptors18
Rotatable Bonds63
Heavy Atoms101
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001433.05
LogP ≤ 513.39
H-Bond Donors ≤ 512
H-Bond Acceptors ≤ 1018

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze (15Z,18Z,21Z,24Z,27Z)-N-[(4E,8E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxytetratriaconta-4,8-dien-2-yl]triaconta-15,18,21,24,27-pentaenamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (15Z,18Z,21Z,24Z,27Z)-N-[(4E,8E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxytetratriaconta-4,8-dien-2-yl]triaconta-15,18,21,24,27-pentaenamide?
The IUPAC name of (15Z,18Z,21Z,24Z,27Z)-N-[(4E,8E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxytetratriaconta-4,8-dien-2-yl]triaconta-15,18,21,24,27-pentaenamide (CID 165207437) is (15Z,18Z,21Z,24Z,27Z)-N-[(4E,8E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxytetratriaconta-4,8-dien-2-yl]triaconta-15,18,21,24,27-pentaenamide.
What is the SMILES notation for (15Z,18Z,21Z,24Z,27Z)-N-[(4E,8E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxytetratriaconta-4,8-dien-2-yl]triaconta-15,18,21,24,27-pentaenamide?
The canonical SMILES for (15Z,18Z,21Z,24Z,27Z)-N-[(4E,8E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxytetratriaconta-4,8-dien-2-yl]triaconta-15,18,21,24,27-pentaenamide is CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCCCCCCCCCC(=O)NC(COC1OC(CO)C(OC2OC(CO)C(OC3OC(CO)C(O)C(O)C3O)C(O)C2O)C(O)C1O)C(O)/C=C/CC/C=C/CCCCCCCCCCCCCCCCCCCCCCCCC.
What is the InChIKey of (15Z,18Z,21Z,24Z,27Z)-N-[(4E,8E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxytetratriaconta-4,8-dien-2-yl]triaconta-15,18,21,24,27-pentaenamide?
The InChIKey is FCSMEKQLGBQKSX-ZGZGWSBGSA-N. The full InChI is InChI=1S/C82H145NO18/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-32-34-35-37-39-41-43-45-47-49-51-53-55-57-59-66(87)65(83-70(88)60-58-56-54-52-50-48-46-44-42-40-38-36-33-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2)64-96-80-76(94)73(91)78(68(62-85)98-80)101-82-77(95)74(92)79(69(63-86)99-82)100-81-75(93)72(90)71(89)67(61-84)97-81/h6,8,12,14,18,20,24,26,30,33,49,51,57,59,65-69,71-82,84-87,89-95H,3-5,7,9-11,13,15-17,19,21-23,25,27-29,31-32,34-48,50,52-56,58,60-64H2,1-2H3,(H,83,88)/b8-6-,14-12-,20-18-,26-24-,33-30-,51-49+,59-57+.
What are the key properties of (15Z,18Z,21Z,24Z,27Z)-N-[(4E,8E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxytetratriaconta-4,8-dien-2-yl]triaconta-15,18,21,24,27-pentaenamide?
(15Z,18Z,21Z,24Z,27Z)-N-[(4E,8E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxytetratriaconta-4,8-dien-2-yl]triaconta-15,18,21,24,27-pentaenamide has a molecular weight of 1433.05 g/mol, XLogP of 13.39, 63 rotatable bonds, 12 hydrogen bond donors, and 18 hydrogen bond acceptors.
Where does this data come from?
All data for (15Z,18Z,21Z,24Z,27Z)-N-[(4E,8E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxytetratriaconta-4,8-dien-2-yl]triaconta-15,18,21,24,27-pentaenamide is sourced from PubChem (CID 165207437), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).